Search
for
Sort by
Research 31–60 of 211
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Hidradenitis suppurativa: A folliculotropic disease of innate immune barrier dysfunction?
- Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?
- HuR ablation destabilizes Foxp3 mRNA and impairs regulatory T cell function, contributing to an autoimmune phenotype
- Redefining the Skin Barrier: A Microbiome‐Integrated Multilayered Defense Model
- Blank Spots in the Map of Human Skin: The Challenge for Xenotransplantation
- Cutaneous Lupus Erythematosus
- What's new in the pathogeneses and triggering factors of bullous pemphigoid
- Nanomedicine-based immunotherapy for tissue regeneration
- Biliary fibrosis is an important but neglected pathological feature in hepatobiliary disorders: from molecular mechanisms to clinical implications
- Decreased CD19+CD24hiCD38hi Regulatory B Cells in Alopecia Areata
- Bioinformatics analysis of genes associated with the patchy-type alopecia areata: CD2 may be a new therapeutic target
- TYK2 Inhibition with Deucravacitinib Improves Clinical Outcomes and Resolves Interferon-Driven Inflammation in Lichen Planopilaris
- JAK-centric explainable few-shot gene-expression diagnosis framework for alopecia via MultiPLIER priors and relation-style set-to-set comparison
- Diagnosis and treatment of alopecia areata
- Case Series: Gene Expression Analysis in Canine Vogt-Koyanagi-Harada/Uveodermatologic Syndrome and Vitiligo Reveals Conserved Immunopathogenesis Pathways Between Dog and Human Autoimmune Pigmentary Disorders
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- A mouse model of vitiligo based on endogenous auto-reactive CD8 + T cell targeting skin melanocyte
- Extracellular vesicles in age-related diseases: disease pathogenesis, intervention, and biomarker
- Autophagy: Guardian of Skin Barrier
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- Serum Granulysin Levels in Vitiligo and Alopecia Areata: A Potential Biomarker for Disease Activity and Dermoscopic Evaluation
- The potential of regulatory T cell-based therapies for alopecia areata
- Sp6 downregulation of follistatin gene expression in ameloblasts
- The Pathogenesis of Alopecia Areata in Rodent Models
- Immune Microenvironment of Hair Follicles in Tumor Immunotherapy
- Primary cicatricial alopecia: Recent advances in understanding and management
- Effect of Liquid Blood Concentrates on Cell Proliferation and Cell Cycle- and Apoptosis-Related Gene Expressions in Nonmelanoma Skin Cancer Cells: A Comparative In Vitro Study
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata